II. Background
- Niacin (Nicotinic Acid, Niacinamide, Vitamin B3) is a B Vitamin
- As a component of NADH and NADPH, is involved in many in vivo reactions
- Niacin may be ingested or synthesized from Tryptophan (Essential Amino Acid)
- Food sources of Niacin
- Wheat germ
- Liver
- Fish
- Peanuts
-
Niacin Deficiency (Pellagra)
- Sythesized from Tryptophan and deficiency may be seen in limited diets (e.g. corn) in which Tryptophan is absent
- Pellagra presents with Diarrhea, Dermatitis and Dementia (3D's)
III. Indications
- Older indications that should be reconsidered in light of AIM-High Study (Niacin did not appear effective in these cases)
- Low HDL Cholesterol
- Combination therapy with Statin for Hyperlipidemia
- Indications that are reasonable as of 2013
- Hypertriglyceridemia
- Hyperlipidemia Management in patients intolerant to Statins
IV. Effects: Lipids
- HDL increased (15-35%)
- No other agent raises HDL as much as Niacin
- However Niacin related HDL increase did not effect outcomes in 2011 AIM-HIGH study (prematurely stopped)
- Triglycerides decreased (20-50%)
-
LDL Cholesterol decreased (10-25%)
- Significantly lowers LDL only at high dose
- Not a first-line agent for lowering LDL
V. Efficacy
- Does not affect all cause mortality
- Statin with Niacin did not show benefit beyond Statin alone in AIM-HIGH study (2011)
- Studies since the 1980s to today have suggested coronary disease risk reduction, but benefit may be aside from affect on HDL Cholesterol
VI. Adverse effects
- Flushing
- Pruritus
- Skin irritation of neck and face
- Gastrointestinal upset (Dyspepsia, Diarrhea)
- Blurred Vision
- Fatigue
- Glucose intollerance
- Hyperuricemia and gout
- Peptic Ulcer Disease exacerbation
- Hepatic toxicity with sustained release forms
-
Diabetes Mellitus (when Niacin is combined with a Statin)
- Increases risk of developing diabetes or worsening diabetes control
- (2014) N Engl J Med 2014 371:203-12 [PubMed]
VII. Adverse Effects: Compliance and tolerance
VIII. Contraindications
- Absolute
- Relative
- Type II Diabetes Mellitus
- Severe gout
- Hyperuricemia
IX. Preparations: Niacin
- Crystalline Niacin
- Niaspan (preferred)
- Safest of Niacins (only 4% GI side effects)
- More expensive than crystalline Niacin
- Example protocol for initiating doses
- References
- McBride (2003) New Therapeutics Lecture, Cable, WI
- Agents to avoid
- Avoid flush-free or no-flush Niacin
- Avoid Slow Niacin (Sustained Release)
- Decreased Safety due to hepatotoxicity
X. Preparations: Niacin combined with other agents
- Advicor: Niaspan (500-1000 mg) and Lovastatin (20-40 mg)
- Simcor: Niaspan (500-1000 mg) and Simvastatin (20 mg)
- Cordaptive: Niacin (extended release) with Laropiprant (to reduce Flushing)
Images: Related links to external sites (from Bing)
Related Studies
niacin (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
NIACIN ER 1,000 MG TABLET | Generic | $0.30 each |
NIACIN ER 500 MG TABLET | Generic | $0.17 each |
NIACIN ER 750 MG TABLET | Generic | $0.40 each |